Intravenous immune globulin (IVIG) drugs are sterilized solutions of antibodies made from human plasma, and are used to treat primary immune deficiency and other immune-related conditions. IVIG drugs have, however, been linked to thrombotic events mediated largely by coagulation factor XI(a), which co-purifies with immune globulin as a contaminant. As a result, IVIG drug manufactures are recommended to routinely test the thrombogenicity of their IVIG product via detection of XI(a) activity in a specially designed thrombin generation assays. In addition, a myriad of testing for identity and impurities is also required for the release of an IVIG lot into the marketplace. HBS performs the following testing on IVIG drug products.
Analytical methods for IVIG
| Assay Method | Utility/Intended Use |
| Thrombin generation assay (TGA) | Quantitative Test for Process-Related Impurities: Factor XIa and “Factor XIa-like” activity |
| Factor XIa chromogenic assay | Quantitative detection of FXIa present in the sample |
| NAPTT | Detection of active contaminant clotting Factors with thrombogenic potential |
| Protein G HPLC | Identification/quantitation test for purity |
| Size exclusion HPLC (SE-HPLC) | Identity/Molecular Size Distribution |
| SDS-PAGE, non-reduced | Identification/Quantitative Test for Purity |
| SDS-PAGE, reduced | Identification/Quantitative Test for Purity |
| Total protein, Bradford assay | Protein concentration |
| Na-Caprylate | Quantitative Test for Process-Related Impurity: Sodium Caprylate |
| Glycine | Quantitative Test for Excipient: Glycine |
| PKA | Quantitative Test for Process-Related Impurity: PKA |
| Plasmin | Quantitative Test for Process-Related Impurity: Plasmin |
| Plasminogen | Quantitative Test for Process-Related Impurity: Plasminogen |
| Anti-complement activity | Quantitative Test for Process-Related Impurities: Anti-complement antibodies |
| Hemagglutination for Anti-A and Anti-B | Quantify levels of anti-A and anti-B antibodies |
| Anti-D antibodies | Quantify levels of anti-D (Rh factor) antibodies |
| Fc Function Test | Ensuring that Fc-mediated functions are maintained |
| IgA Assay (ELISA) | Quantitative measurement of IgA contaminant |
| IgM Assay (ELISA) | Quantitative measurement of IgM contaminant |
| Fibrinogen (ELISA) | Quantitative measurement of Fibrinogen |
| IgG Sub-Class Characterization (ELISA) | Ensuring distribution of IgG subclasses is maintained during purification |
| pH | Ensure Correct pH of Drug Product |
| Osmolality | Ensure Correct Osmolality of Drug Product |
To Learn More
Contact us using the form on the right or call us at +1 (802) 878-1777 to learn more about how we can assist you with characterizing your IVIG drug product.
